Cargando…
Oncolytic Viral Therapy for Mesothelioma
The limited effectiveness of conventional therapy for malignant pleural mesothelioma demands innovative approaches to this difficult disease. Even with aggressive multimodality treatment of surgery, radiation, and/or chemotherapy, the median survival is only 1–2 years depending on stage and histolog...
Autores principales: | Pease, Daniel F., Kratzke, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573749/ https://www.ncbi.nlm.nih.gov/pubmed/28884088 http://dx.doi.org/10.3389/fonc.2017.00179 |
Ejemplares similares
-
Novel oncolytic viral therapies in patients with thoracic malignancies
por: Ahmad, Zeeshan, et al.
Publicado: (2016) -
Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2019) -
Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2020) -
Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma
por: Jacobson, Blake A., et al.
Publicado: (2017) -
Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy
por: Li, H, et al.
Publicado: (2010)